Ranbaxy recalls over 4,000 cartons of acne drug in US

Ranbaxy Laboratories has initiated a voluntary recall of 4,348 cartons of its best-selling drug Sotret (isotretinoin, 40 mg) used to treat acne in the US, as they are a part of one batch of tablets which were found to be ‘out of specification’. (Source: The Economic Times Healthcare and Biotech News) MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed – updated hourly from thousands of authoritative health and news sources.

Read this article:
Ranbaxy recalls over 4,000 cartons of acne drug in US

Related posts:

1. Ranbaxy recalls drug in US Ranbaxy Laboratories is voluntarily recalling a batch of its best-selling...
2. Ranbaxy recalls drugs for skin disease from US market Pharma major Ranbaxy Laboratories today said its US-based subsidiary, Ranbaxy...
3. Controversial acne drug available in SA While Americans have witnessed the sudden disappearance of a blockbuster...
4. Acne drug prevents HIV breakout Scientists have found that a safe and inexpensive antibiotic in...
5. More evidence ties acne drug to bowel disease NEW YORK (Reuters Health) - Adding to evidence that the...

Leave a comment

Name (required)

E-mail (required)

URI

Your Message